PK of Efavirenz & Lopinavir Nano-formulations in Healthy Volunteers

NCT02631473 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

50

Enrollment

OTHER

Sponsor class

Stopped Study is on hold whilst a grant application for further funding is put together

Conditions

HIV

Interventions

DRUG: 50mg NANO-efavirenz
DRUG: 400mg NANO-Lopinavir
DRUG: 200mg NANO-Lopinavir
DRUG: 100mg Ritonavir
DRUG: 300mg NANO-Efavirenz
DRUG: 600mg Sustiva
DRUG: 200mg NANO-Efavirenz
DRUG: Kaletra® (lopinavir 400mg/ritonavir 100mg)
DRUG: +/- 200mg NANO-Lopinavir
DRUG: +/- 200mg ritonavir NORVIR
DRUG: 400mg Sustiva

Sponsor

St Stephens Aids Trust

Collaborators

[object Object]